New pill may keep heart inflammation away without lifelong drugs
Disease control
Recruiting now
This study tests whether CardiolRx can prevent pericarditis (inflammation around the heart) from coming back. About 110 adults who have been stable on an IL-1 blocker for at least a year will stop that drug and start CardiolRx or a placebo. The goal is to see if more people stay …
Phase: PHASE3 • Sponsor: Cardiol Therapeutics Inc. • Aim: Disease control
Last updated May 11, 2026 20:47 UTC